Loading…

Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability

Antibiotics become less effective in treating infectious diseases as resistance increases. S taphylococcus aureus is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chime...

Full description

Saved in:
Bibliographic Details
Published in:AMB Express 2024-12, Vol.14 (1), p.143-12, Article 143
Main Authors: Momen, Sanaz, Soleimani, Neda, Azizmohseni, Farzaneh, Ahmadbeigi, Yasaman, Borhani, Seddigheh, Amini-Bayat, Zahra
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3
container_end_page 12
container_issue 1
container_start_page 143
container_title AMB Express
container_volume 14
creator Momen, Sanaz
Soleimani, Neda
Azizmohseni, Farzaneh
Ahmadbeigi, Yasaman
Borhani, Seddigheh
Amini-Bayat, Zahra
description Antibiotics become less effective in treating infectious diseases as resistance increases. S taphylococcus aureus is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chimeric endolysin has three domains derived from SAL1 and lysostaphin, which target the peptide bridge of peptidoglycan. In this study purified ZAM-MSC (with yield of 30 mg/lit) had bactericidal activity against methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) at low concentrations (2.38 μg/ml and 1.88 μg/ml, respectively). The antibacterial spectrum revealed that ZAM-MSC was active against diverse Staphylococci . it has maintained 100% stability after 24 h incubation in pH 5 to 10 against S. aureus , as well as demonstrated significant thermostability and maintained nearly its full activity at different temperatures (4–42 °C) up to 1 day of incubation. The anti-biofilm activity of various concentrations of ZAM-MSC against MSSA and MRSA biofilms was not dose-dependent, and antibiofilm activity was observed even at low concentrations (14 μg/ml). Further, the molecular dynamics simulations demonstrated that the ZAM-MSC chimer and its parent proteins remained dynamically stable, showing similar flexibility despite the size and hydrogen bond number differences. In conclusion, the study reveals that chimeric ZAM-MSC is a distinctive enzyme with exceptional biochemical properties and rapid lytic activity against Staphylococci .
doi_str_mv 10.1186/s13568-024-01812-2
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_798f6c85027a49c3a5fcb696e23fb921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_798f6c85027a49c3a5fcb696e23fb921</doaj_id><sourcerecordid>3149542010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhSMEolXpH2CBLLFhE_A78bIaUahUhMRjbd3Y1zMeJXGxM6qGX4_blIJY4I2te79zfO3TNC8ZfctYr98VJpTuW8plS1nPeMufNKecGdbSXqmnf51PmvNS9rQuRanR6nlzIkzHpRD6tImbHWRwC-b4E5aYZgKzJ0NMcQ4pT7XkagXGY4mFpECAzHhL3C5OVeEIzj7d9apsC3EuC_n05esFuY3LjmwzwkLKAkMc43J80TwLMBY8f9jPmu-X779tPrbXnz9cbS6uWydkz9uedUbRQYLmA6AeEFkIznNkgisvAwipqEJBjZTKDeiF8KqXUjCHHp0XZ83V6usT7O1NjhPko00Q7X0h5a2FXJ81ou1MH7TrFeUdSOMEqOAGbTRyEQbDWfV6s3rd5PTjgGWxUywOxxFmTIdiBZNGSU4Zrejrf9B9OuT6cyslRB2_qxRfKZdTKRnD44CM2rtc7Zqrrbna-1wtr6JXD9aHYUL_KPmdYgXECpTamreY_9z9H9tfP1-teg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3149333257</pqid></control><display><type>article</type><title>Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><source>Free Full-Text Journals in Chemistry</source><creator>Momen, Sanaz ; Soleimani, Neda ; Azizmohseni, Farzaneh ; Ahmadbeigi, Yasaman ; Borhani, Seddigheh ; Amini-Bayat, Zahra</creator><creatorcontrib>Momen, Sanaz ; Soleimani, Neda ; Azizmohseni, Farzaneh ; Ahmadbeigi, Yasaman ; Borhani, Seddigheh ; Amini-Bayat, Zahra</creatorcontrib><description>Antibiotics become less effective in treating infectious diseases as resistance increases. S taphylococcus aureus is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chimeric endolysin has three domains derived from SAL1 and lysostaphin, which target the peptide bridge of peptidoglycan. In this study purified ZAM-MSC (with yield of 30 mg/lit) had bactericidal activity against methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) at low concentrations (2.38 μg/ml and 1.88 μg/ml, respectively). The antibacterial spectrum revealed that ZAM-MSC was active against diverse Staphylococci . it has maintained 100% stability after 24 h incubation in pH 5 to 10 against S. aureus , as well as demonstrated significant thermostability and maintained nearly its full activity at different temperatures (4–42 °C) up to 1 day of incubation. The anti-biofilm activity of various concentrations of ZAM-MSC against MSSA and MRSA biofilms was not dose-dependent, and antibiofilm activity was observed even at low concentrations (14 μg/ml). Further, the molecular dynamics simulations demonstrated that the ZAM-MSC chimer and its parent proteins remained dynamically stable, showing similar flexibility despite the size and hydrogen bond number differences. In conclusion, the study reveals that chimeric ZAM-MSC is a distinctive enzyme with exceptional biochemical properties and rapid lytic activity against Staphylococci .</description><identifier>ISSN: 2191-0855</identifier><identifier>EISSN: 2191-0855</identifier><identifier>DOI: 10.1186/s13568-024-01812-2</identifier><identifier>PMID: 39724336</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antibiotic resistance ; Antibiotics ; Bactericidal activity ; Biofilm ; Biofilms ; Biomedical and Life Sciences ; Biotechnology ; Bond number ; Chemical bonds ; Chimeric endolysin ; Drug resistance ; Dynamic stability ; Hydrogen bonds ; Infectious diseases ; Life Sciences ; Low concentrations ; Lysostaphin ; Methicillin ; Microbial Genetics and Genomics ; Microbiology ; Molecular dynamics ; MRSA ; Original Article ; Peptidoglycans ; Staphylococcus aureus ; Staphylococcus infections ; Thermal stability</subject><ispartof>AMB Express, 2024-12, Vol.14 (1), p.143-12, Article 143</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>Copyright Springer Nature B.V. Dec 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3</cites><orcidid>0000-0003-2667-0486</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3149333257/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3149333257?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25752,27923,27924,37011,37012,44589,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39724336$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Momen, Sanaz</creatorcontrib><creatorcontrib>Soleimani, Neda</creatorcontrib><creatorcontrib>Azizmohseni, Farzaneh</creatorcontrib><creatorcontrib>Ahmadbeigi, Yasaman</creatorcontrib><creatorcontrib>Borhani, Seddigheh</creatorcontrib><creatorcontrib>Amini-Bayat, Zahra</creatorcontrib><title>Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability</title><title>AMB Express</title><addtitle>AMB Expr</addtitle><addtitle>AMB Express</addtitle><description>Antibiotics become less effective in treating infectious diseases as resistance increases. S taphylococcus aureus is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chimeric endolysin has three domains derived from SAL1 and lysostaphin, which target the peptide bridge of peptidoglycan. In this study purified ZAM-MSC (with yield of 30 mg/lit) had bactericidal activity against methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) at low concentrations (2.38 μg/ml and 1.88 μg/ml, respectively). The antibacterial spectrum revealed that ZAM-MSC was active against diverse Staphylococci . it has maintained 100% stability after 24 h incubation in pH 5 to 10 against S. aureus , as well as demonstrated significant thermostability and maintained nearly its full activity at different temperatures (4–42 °C) up to 1 day of incubation. The anti-biofilm activity of various concentrations of ZAM-MSC against MSSA and MRSA biofilms was not dose-dependent, and antibiofilm activity was observed even at low concentrations (14 μg/ml). Further, the molecular dynamics simulations demonstrated that the ZAM-MSC chimer and its parent proteins remained dynamically stable, showing similar flexibility despite the size and hydrogen bond number differences. In conclusion, the study reveals that chimeric ZAM-MSC is a distinctive enzyme with exceptional biochemical properties and rapid lytic activity against Staphylococci .</description><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Bactericidal activity</subject><subject>Biofilm</subject><subject>Biofilms</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnology</subject><subject>Bond number</subject><subject>Chemical bonds</subject><subject>Chimeric endolysin</subject><subject>Drug resistance</subject><subject>Dynamic stability</subject><subject>Hydrogen bonds</subject><subject>Infectious diseases</subject><subject>Life Sciences</subject><subject>Low concentrations</subject><subject>Lysostaphin</subject><subject>Methicillin</subject><subject>Microbial Genetics and Genomics</subject><subject>Microbiology</subject><subject>Molecular dynamics</subject><subject>MRSA</subject><subject>Original Article</subject><subject>Peptidoglycans</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus infections</subject><subject>Thermal stability</subject><issn>2191-0855</issn><issn>2191-0855</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kUtv1DAUhSMEolXpH2CBLLFhE_A78bIaUahUhMRjbd3Y1zMeJXGxM6qGX4_blIJY4I2te79zfO3TNC8ZfctYr98VJpTuW8plS1nPeMufNKecGdbSXqmnf51PmvNS9rQuRanR6nlzIkzHpRD6tImbHWRwC-b4E5aYZgKzJ0NMcQ4pT7XkagXGY4mFpECAzHhL3C5OVeEIzj7d9apsC3EuC_n05esFuY3LjmwzwkLKAkMc43J80TwLMBY8f9jPmu-X779tPrbXnz9cbS6uWydkz9uedUbRQYLmA6AeEFkIznNkgisvAwipqEJBjZTKDeiF8KqXUjCHHp0XZ83V6usT7O1NjhPko00Q7X0h5a2FXJ81ou1MH7TrFeUdSOMEqOAGbTRyEQbDWfV6s3rd5PTjgGWxUywOxxFmTIdiBZNGSU4Zrejrf9B9OuT6cyslRB2_qxRfKZdTKRnD44CM2rtc7Zqrrbna-1wtr6JXD9aHYUL_KPmdYgXECpTamreY_9z9H9tfP1-teg</recordid><startdate>20241226</startdate><enddate>20241226</enddate><creator>Momen, Sanaz</creator><creator>Soleimani, Neda</creator><creator>Azizmohseni, Farzaneh</creator><creator>Ahmadbeigi, Yasaman</creator><creator>Borhani, Seddigheh</creator><creator>Amini-Bayat, Zahra</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><general>SpringerOpen</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>L6V</scope><scope>LK8</scope><scope>M7P</scope><scope>M7S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2667-0486</orcidid></search><sort><creationdate>20241226</creationdate><title>Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability</title><author>Momen, Sanaz ; Soleimani, Neda ; Azizmohseni, Farzaneh ; Ahmadbeigi, Yasaman ; Borhani, Seddigheh ; Amini-Bayat, Zahra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Bactericidal activity</topic><topic>Biofilm</topic><topic>Biofilms</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnology</topic><topic>Bond number</topic><topic>Chemical bonds</topic><topic>Chimeric endolysin</topic><topic>Drug resistance</topic><topic>Dynamic stability</topic><topic>Hydrogen bonds</topic><topic>Infectious diseases</topic><topic>Life Sciences</topic><topic>Low concentrations</topic><topic>Lysostaphin</topic><topic>Methicillin</topic><topic>Microbial Genetics and Genomics</topic><topic>Microbiology</topic><topic>Molecular dynamics</topic><topic>MRSA</topic><topic>Original Article</topic><topic>Peptidoglycans</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus infections</topic><topic>Thermal stability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Momen, Sanaz</creatorcontrib><creatorcontrib>Soleimani, Neda</creatorcontrib><creatorcontrib>Azizmohseni, Farzaneh</creatorcontrib><creatorcontrib>Ahmadbeigi, Yasaman</creatorcontrib><creatorcontrib>Borhani, Seddigheh</creatorcontrib><creatorcontrib>Amini-Bayat, Zahra</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>MEDLINE - Academic</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>AMB Express</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Momen, Sanaz</au><au>Soleimani, Neda</au><au>Azizmohseni, Farzaneh</au><au>Ahmadbeigi, Yasaman</au><au>Borhani, Seddigheh</au><au>Amini-Bayat, Zahra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability</atitle><jtitle>AMB Express</jtitle><stitle>AMB Expr</stitle><addtitle>AMB Express</addtitle><date>2024-12-26</date><risdate>2024</risdate><volume>14</volume><issue>1</issue><spage>143</spage><epage>12</epage><pages>143-12</pages><artnum>143</artnum><issn>2191-0855</issn><eissn>2191-0855</eissn><abstract>Antibiotics become less effective in treating infectious diseases as resistance increases. S taphylococcus aureus is a global problem due to its ability to form biofilms and resistance mechanisms. Phage endolysin is one of the most promising methods for combating antibiotic resistance. ZAM-MSC chimeric endolysin has three domains derived from SAL1 and lysostaphin, which target the peptide bridge of peptidoglycan. In this study purified ZAM-MSC (with yield of 30 mg/lit) had bactericidal activity against methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) at low concentrations (2.38 μg/ml and 1.88 μg/ml, respectively). The antibacterial spectrum revealed that ZAM-MSC was active against diverse Staphylococci . it has maintained 100% stability after 24 h incubation in pH 5 to 10 against S. aureus , as well as demonstrated significant thermostability and maintained nearly its full activity at different temperatures (4–42 °C) up to 1 day of incubation. The anti-biofilm activity of various concentrations of ZAM-MSC against MSSA and MRSA biofilms was not dose-dependent, and antibiofilm activity was observed even at low concentrations (14 μg/ml). Further, the molecular dynamics simulations demonstrated that the ZAM-MSC chimer and its parent proteins remained dynamically stable, showing similar flexibility despite the size and hydrogen bond number differences. In conclusion, the study reveals that chimeric ZAM-MSC is a distinctive enzyme with exceptional biochemical properties and rapid lytic activity against Staphylococci .</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>39724336</pmid><doi>10.1186/s13568-024-01812-2</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-2667-0486</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2191-0855
ispartof AMB Express, 2024-12, Vol.14 (1), p.143-12, Article 143
issn 2191-0855
2191-0855
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_798f6c85027a49c3a5fcb696e23fb921
source Open Access: PubMed Central; Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access ; Free Full-Text Journals in Chemistry
subjects Antibiotic resistance
Antibiotics
Bactericidal activity
Biofilm
Biofilms
Biomedical and Life Sciences
Biotechnology
Bond number
Chemical bonds
Chimeric endolysin
Drug resistance
Dynamic stability
Hydrogen bonds
Infectious diseases
Life Sciences
Low concentrations
Lysostaphin
Methicillin
Microbial Genetics and Genomics
Microbiology
Molecular dynamics
MRSA
Original Article
Peptidoglycans
Staphylococcus aureus
Staphylococcus infections
Thermal stability
title Characterization and bioinformatic analysis of a new chimeric endolysin against MRSA with great stability
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T02%3A10%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20and%20bioinformatic%20analysis%20of%20a%20new%20chimeric%20endolysin%20against%20MRSA%20with%20great%20stability&rft.jtitle=AMB%20Express&rft.au=Momen,%20Sanaz&rft.date=2024-12-26&rft.volume=14&rft.issue=1&rft.spage=143&rft.epage=12&rft.pages=143-12&rft.artnum=143&rft.issn=2191-0855&rft.eissn=2191-0855&rft_id=info:doi/10.1186/s13568-024-01812-2&rft_dat=%3Cproquest_doaj_%3E3149542010%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3482-817950b4a62bae6bee1ffcd2e1325d4fa34505e309445cbed33d584431cedecd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3149333257&rft_id=info:pmid/39724336&rfr_iscdi=true